Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca appoints Lisa Anson UK country president

One of her priorities will be to build relationships with the NHS

Lisa Anson - AstraZenecaAstraZeneca has promoted Lisa Anson to country president of its UK marketing company.

She will take charge of AstraZeneca's entire UK sales force as well as a sales and marketing team based in Luton and a clinical research group in Edinburgh.

The position is not Anson's first role with the AstraZeneca's UK marketing company, having previously worked as both head of primary care and head of speciality care.

Anson has also previously served as vice president of emerging brands within the company's global marketing and sales operations, and has also held a number of senior global brand roles at the pharma company.

She takes over the UK presidency from Mark Jones, who AstraZeneca has appointed area vice president for Southern Europe and Israel.

The company said Anson's priority would be to build a stronger relationship with the UK's NHS, which is currently undergoing major reforms, with a focus on delivering innovative medicines to patients sooner.

This is in line with comments from Stephen Whitehead, CEO of the Association of the British Pharmaceutical (ABPI), who said in an interview with PMLiVE: “The only way we can help the NHS is by being a partner.”

Anson will start her new role at AstraZeneca on January 1, 2012.

15th December 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....